• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌和结直肠癌患者身体成分评估及其与临床结局的关联

Assessment of body composition and association with clinical outcomes in patients with lung and colorectal cancer.

作者信息

Sakai Naomi S, Bhagwanani Anisha, Bray Timothy Jp, Hall-Craggs Margaret A, Taylor Stuart Andrew

机构信息

University College London Hospital, London, UK.

出版信息

BJR Open. 2021 Nov 26;3(1):20210048. doi: 10.1259/bjro.20210048. eCollection 2021.

DOI:10.1259/bjro.20210048
PMID:35707759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9185845/
Abstract

OBJECTIVES

To assess body composition in patients with non-small cell lung cancer (NSCLC) and colorectal cancer using whole-body MRI and relate this to clinical outcomes.

METHODS

53 patients with NSCLC (28 males, 25 females; mean age 66.9) and 74 patients with colorectal cancer (42 males, 32 females; mean age 62.9) underwent staging whole-body MRI scans, which were post-processed to derive fat mass (FM), fat free mass (FFM) and skeletal muscle (SM) indices and SM fat fraction (FF). These were compared between the two cancer cohorts using two-sided -tests and the chi-squared test. Measurements of body composition were correlated with outcomes including length of hospital stay, metastatic status and mortality.

RESULTS

Patients with NSCLC had significantly lower FFM ( = 0.0071) and SM ( = 0.0084) indices. Mean SM FF was greater in patients with NSCLC ( = 0.0124) and was associated with longer hospital stay (). There was no significant relationship between FM, FFM and SM indices and length of hospital stay, metastatic status or mortality.

CONCLUSIONS

Patients with NSCLC had lower FFM and SM indices than patients with colorectal cancer and greater SMFF, indicating lower SM mass with fatty infiltration. These findings reflect differences in the phenotype of the two groups and suggest patients with lung cancer are more likely to require additional nutritional support.

ADVANCES IN KNOWLEDGE

Body composition differs between NSCLC and colorectal cancer. Patients with NSCLC have both a reduced SM mass and greater SM FF suggesting that they are more nutritionally deplete than patients with colorectal cancer.

摘要

目的

使用全身磁共振成像(MRI)评估非小细胞肺癌(NSCLC)和结直肠癌患者的身体成分,并将其与临床结局相关联。

方法

53例NSCLC患者(28例男性,25例女性;平均年龄66.9岁)和74例结直肠癌患者(42例男性,32例女性;平均年龄62.9岁)接受了分期全身MRI扫描,对扫描结果进行后处理以得出脂肪量(FM)、去脂体重(FFM)、骨骼肌(SM)指数和SM脂肪分数(FF)。使用双侧t检验和卡方检验对这两个癌症队列之间的上述指标进行比较。身体成分测量结果与包括住院时间、转移状态和死亡率在内的结局相关联。

结果

NSCLC患者的FFM指数(P = 0.0071)和SM指数(P = 0.0084)显著更低。NSCLC患者的平均SM FF更高(P = 0.0124),且与更长的住院时间相关(P<0.05)。FM、FFM和SM指数与住院时间、转移状态或死亡率之间无显著关系。

结论

NSCLC患者的FFM和SM指数低于结直肠癌患者,且SMFF更高,表明SM质量更低且存在脂肪浸润。这些发现反映了两组患者表型的差异,提示肺癌患者更可能需要额外的营养支持。

知识进展

NSCLC和结直肠癌患者的身体成分存在差异。NSCLC患者的SM质量降低且SM FF更高,表明他们比结直肠癌患者的营养消耗更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4212/9185845/6402ae5de3aa/bjro.20210048.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4212/9185845/1114f6ad81a0/bjro.20210048.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4212/9185845/6402ae5de3aa/bjro.20210048.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4212/9185845/1114f6ad81a0/bjro.20210048.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4212/9185845/6402ae5de3aa/bjro.20210048.g002.jpg

相似文献

1
Assessment of body composition and association with clinical outcomes in patients with lung and colorectal cancer.肺癌和结直肠癌患者身体成分评估及其与临床结局的关联
BJR Open. 2021 Nov 26;3(1):20210048. doi: 10.1259/bjro.20210048. eCollection 2021.
2
Multi-frequency bioelectrical impedance analysis (BIA) compared to magnetic resonance imaging (MRI) for estimation of fat-free mass in colorectal cancer patients treated with chemotherapy.多频生物电阻抗分析(BIA)与磁共振成像(MRI)在接受化疗的结直肠癌患者无脂肪组织质量评估中的比较
Clin Nutr ESPEN. 2016 Dec;16:8-15. doi: 10.1016/j.clnesp.2016.09.003. Epub 2016 Oct 4.
3
Assessment of body composition in cystic fibrosis: agreement between skinfold measurement and densitometry.囊性纤维化患者身体成分评估:皮褶厚度测量与密度测定的一致性。
Nutr Hosp. 2022 Mar 29;39(2):376-382. doi: 10.20960/nh.03836.
4
Magnetic resonance imaging-measured skeletal muscle mass to fat-free mass ratio increases with increasing levels of fat-free mass.磁共振成像测量的骨骼肌质量与去脂体重之比随去脂体重水平的增加而增加。
J Sports Med Phys Fitness. 2019 Apr;59(4):619-623. doi: 10.23736/S0022-4707.18.08683-8. Epub 2018 Sep 27.
5
Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults.通过磁共振成像测量的日本年轻成年人全身骨骼肌质量的性别差异及其分布
Br J Sports Med. 2003;37(5):436-40. doi: 10.1136/bjsm.37.5.436.
6
Fat-Free Mass and Skeletal Muscle Mass Gain Are Associated with Diabetes Remission after Laparoscopic Sleeve Gastrectomy in Males but Not in Females.男性腹腔镜袖状胃切除术后体脂量和骨骼肌量的增加与糖尿病缓解相关,但女性并非如此。
Int J Environ Res Public Health. 2022 Jan 16;19(2):978. doi: 10.3390/ijerph19020978.
7
Preoperative small airway dysfunction is associated with skeletal muscle loss in early-stage non-small cell lung cancer.术前小气道功能障碍与早期非小细胞肺癌患者的骨骼肌丢失有关。
Clin Nutr. 2023 Oct;42(10):1932-1939. doi: 10.1016/j.clnu.2023.08.002. Epub 2023 Aug 12.
8
Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy.免疫治疗晚期非小细胞肺癌的人体成分分析。
JAMA Oncol. 2024 Jun 1;10(6):773-783. doi: 10.1001/jamaoncol.2024.1120.
9
Skeletal muscle mass in human athletes: What is the upper limit?人类运动员的骨骼肌质量:上限是多少?
Am J Hum Biol. 2018 May;30(3):e23102. doi: 10.1002/ajhb.23102. Epub 2018 Jan 22.
10
Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity.脂肪和去脂体重作为与肌少症性肥胖相关的身体成分评估的重要决定因素。
Rocz Panstw Zakl Hig. 2023;74(1):59-69. doi: 10.32394/rpzh.2023.0243.

引用本文的文献

1
Exchange of Quantitative Computed Tomography Assessed Body Composition Data Using Fast Healthcare Interoperability Resources as a Necessary Step Toward Interoperable Integration of Opportunistic Screening Into Clinical Practice: Methodological Development Study.使用快速医疗保健互操作性资源交换定量计算机断层扫描评估的身体成分数据,作为将机会性筛查可操作地整合到临床实践中的必要步骤:方法学开发研究
J Med Internet Res. 2025 May 21;27:e68750. doi: 10.2196/68750.
2
Medical imaging in cancer cachexia.癌症恶病质中的医学影像学。
Radiologie (Heidelb). 2024 Nov;64(Suppl 1):10-15. doi: 10.1007/s00117-024-01346-5. Epub 2024 Jul 12.
3

本文引用的文献

1
Body composition and metastatic prostate cancer survivorship.身体成分与转移性前列腺癌生存状况。
Cancer Treat Res Commun. 2021;27:100322. doi: 10.1016/j.ctarc.2021.100322. Epub 2021 Jan 24.
2
Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.肌少症性肥胖:隐匿性肌肉萎缩及其对癌症治疗生存和并发症的影响。
Ann Oncol. 2018 Feb;29 Suppl 2:ii1-ii9. doi: 10.1093/annonc/mdx810. Epub 2019 Dec 4.
3
Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
Obesity and lung cancer-a narrative review.
肥胖与肺癌——一篇叙述性综述
J Thorac Dis. 2023 May 30;15(5):2806-2823. doi: 10.21037/jtd-22-1835. Epub 2023 May 8.
计算机断层扫描评估的骨骼肌量作为肺癌手术结局的预测因子。
Ann Thorac Surg. 2019 Nov;108(5):1555-1564. doi: 10.1016/j.athoracsur.2019.04.090. Epub 2019 Jun 19.
4
Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis.肌肉减少症对肺癌预后的预测价值:系统评价和荟萃分析。
Chest. 2019 Jul;156(1):101-111. doi: 10.1016/j.chest.2019.04.115. Epub 2019 May 22.
5
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.全身 MRI 与标准影像学通路在新诊断非小细胞肺癌转移疾病中的诊断准确性:前瞻性 Streamline L 试验。
Lancet Respir Med. 2019 Jun;7(6):523-532. doi: 10.1016/S2213-2600(19)30090-6. Epub 2019 May 9.
6
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.新发结直肠癌转移病灶的全身 MRI 与标准影像学检测路径的诊断准确性:前瞻性 Streamline C 试验
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):529-537. doi: 10.1016/S2468-1253(19)30056-1. Epub 2019 May 9.
7
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.PD-1 抑制剂治疗晚期非小细胞肺癌患者中肌少症的影响:一项初步回顾性研究。
Sci Rep. 2019 Feb 21;9(1):2447. doi: 10.1038/s41598-019-39120-6.
8
Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis.胃癌患者的身体成分评估和肌肉减少症:系统评价和荟萃分析。
Gastric Cancer. 2019 Jan;22(1):10-22. doi: 10.1007/s10120-018-0882-2. Epub 2018 Oct 1.
9
Implications of low muscle mass across the continuum of care: a narrative review.贯穿整个医疗保健连续体的低肌肉质量的影响:叙述性综述。
Ann Med. 2018 Dec;50(8):675-693. doi: 10.1080/07853890.2018.1511918. Epub 2018 Sep 12.
10
Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition.保留肌肉量作为一种减轻癌症化疗对身体组成毒性作用的策略。
Curr Opin Support Palliat Care. 2018 Dec;12(4):420-426. doi: 10.1097/SPC.0000000000000382.